Radiotherapy & Oncology
Volume 97, Issue 1 , Pages 136-142 , October 2010

Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy

  • Damian J.J. Farnell

      Affiliations

    • School of Cancer & Enabling Sciences, University of Manchester, Manchester, UK
    • ,
  • Paula Mandall

      Affiliations

    • Clinical Oncology; and
    • ,
  • Carmel Anandadas

      Affiliations

    • Clinical Oncology; and
    • ,
  • Jaqueline Routledge

      Affiliations

    • Clinical Oncology; and
    • ,
  • Meriel P. Burns

      Affiliations

    • Clinical Oncology; and
    • ,
  • John P. Logue

      Affiliations

    • Clinical Oncology; and
    • ,
  • James P. Wylie

      Affiliations

    • Clinical Oncology; and
    • ,
  • Ric Swindell

      Affiliations

    • Medical Statistics, The Christie NHS Foundation Trust, Manchester, UK
    • ,
  • Jac Livsey

      Affiliations

    • Clinical Oncology; and
    • ,
  • Catharine M.L. West

      Affiliations

    • School of Cancer & Enabling Sciences, University of Manchester, Manchester, UK
    • ,
  • Susan E. Davidson

      Affiliations

    • School of Cancer & Enabling Sciences, University of Manchester, Manchester, UK
    • Clinical Oncology; and
    • Corresponding Author InformationCorresponding author. Address: School of Cancer & Enabling Sciences, University of Manchester, c/o The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, United Kingdom.

Received 15 May 2009 ,Revised 28 April 2010 ,Accepted 6 May 2010.

References 

  1. Dishe S, Warburton MF, Jones D, Lartigau E. The recording of morbidity related to radiotherapy. Radiother Oncol. 1989;16:103–108
  2. Bentzen SM, Dörr W, Anscher MS, et al. Normal tissue effects: reporting and analysis. Semin Radiat Oncol. 2003;13:189–202
  3. Trotti A, Bentzen SM. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol. 2004;22:19–22
  4. Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health and disability. J Gerontol. 2003;58:82–91
  5. van der Laan HP, van den Bergh A, Schilstra C, Vlasman R, Meertens H, Langendijk JA. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:1138–1145
  6. LENT SOMA tables. Radiother Oncol 1995;35:17–60.
  7. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 1995;31:1049–91.
  8. Esco Baron R, Baquedano JE. Complications of radiotherapy for invasive bladder cancer: acute and chronic effects. Method of evaluation: measurement by RTOG EORTC, SOMA LENT. Arch Esp Urol. 1999;52:675–683
  9. Anacak Y, Yalman D, Ozsaran Z, Haydaroglu A. Late radiation effects to the rectum and bladder in gynaecologic cancer patients: the comparison of LENT SOMA and RTOG EORTC late-effects scoring systems. Int J Radiat Oncol Biol Phys. 2001;50:1107–1112
  10. Davidson SE, Burns M, Routledge J, et al. Short report: a morbidity scoring system for clinical oncology practice. Questionnaires produced from the LENT SOMA scoring system. Clin Oncol. 2002;14:68–69
  11. Livsey JE, Routledge J, Burns M, et al. Scoring of treatment-related late effects in prostate cancer. Radiother Oncol. 2002;65:109–121
  12. Farnell DJJ, Routledge JA, Hannon R, Logue JP, Cowan RA, Wylie JP, et al. Efficacy of data capture for patient-reported toxicity following radiotherapy treatment for prostate or cervical cancer. Eur J Cancer. 2010;46:534–540
  13. Mornex F, Pavy JJ, Denekamp J, Bolla M. Scoring system of late effects of radiations on normal tissues: the SOMA-LENT scale. Cancer Radiother. 1997;1:622–668
  14. Routledge JA, Burns MP, Swindell R, et al. Evaluation of the LENT SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma. Int J Radiat Oncol Biol Phys. 2003;56:502–510
  15. Fehlauer F, Tribius S, Holler U, et al. Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system. Int J Radiat Oncol Biol Phys. 2003;55:651–658
  16. Ho K, Farnell DJJ, Routledge JA, Burns MP, Slevin N, Sykes A, et al. Developing a CTCAE patient questionnaire for late toxicity after head and neck radiotherapy. Eur J Cancer. 2009;45:1992–1998
  17. Barker CL, Routledge JA, Farnell DJJ, Swindell R, Davidson SE. The impact of radiotherapy late effects on quality of life in gynaecological cancer patients. Br J Cancer. 2009;100:1558–1565
  18. Gorsuch RK. Factor analysis. Philadelphia, London, Toronto: W.B. Saunders Publ.; 1974;
  19. Fayers PM, Hand DJ. Factor analysis, causal indicators, and quality and life. Qual Life Res. 1997;6:139–150
  20. Armstrong JS, Soelberg P. On the interpretation of factor analysis. Psychol Bull. 1968;70:361–364
  21. LENT subjective scoring manual. Available from: http://www.christie.nhs.uk/pro/depts/clinonc/scoring_manual.aspx.
  22. Dunn G. Design and analysis of reliability studies. London: Edward Arnold Publ.; 1989;
  23. Dunn G. Statistical evaluation of measurement errors. 2nd ed.. London: Edward Arnold Publ.; 2004;

PII: S0167-8140(10)00315-4

doi: 10.1016/j.radonc.2010.05.011

Radiotherapy & Oncology
Volume 97, Issue 1 , Pages 136-142 , October 2010

Article Tools

* Image Usage & Resolution